MEDIMMUNE, INC. – Trademark Portfolio

Entity Type: 03

MEDIMMUNE, INC. holds 43 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 30 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 7 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CYTOGAM and SYNAGIS. The owner is based in GAITHERSBURG, MD.